Published in Oncogene on August 03, 2009
Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation. PLoS One (2011) 0.97
2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy. Proc Natl Acad Sci U S A (2012) 0.92
Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Endocrinology (2013) 0.90
PI 3-kinase/Rac1 and ERK1/2 regulate FGF-2-mediated cell proliferation through phosphorylation of p27 at Ser10 by KIS and at Thr187 by Cdc25A/Cdk2. Invest Ophthalmol Vis Sci (2011) 0.89
Targeting oncogenic KRAS in non-small cell lung cancer cells by phenformin inhibits growth and angiogenesis. Am J Cancer Res (2015) 0.88
Mutant AKT1-E17K is oncogenic in lung epithelial cells. Oncotarget (2015) 0.85
PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy. Breast Cancer Res Treat (2013) 0.84
Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy. Oncotarget (2014) 0.82
ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma. Oncogene (2013) 0.79
Independent and core pathways in oncogenic KRAS signaling. Expert Rev Proteomics (2016) 0.78
Loss of p27Kip1 promotes metaplasia in the pancreas via the regulation of Sox9 expression. Oncotarget (2015) 0.77
Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years. Cold Spring Harb Protoc (2015) 0.76
Expression Profiling Identifies Bezafibrate as Potential Therapeutic Drug for Lung Adenocarcinoma. J Cancer (2015) 0.75
Sodium Valproate Enhances the Urethane-Induced Lung Adenomas and Suppresses Malignization of Adenomas in Ovariectomized Female Mice. Int J Endocrinol (2015) 0.75
Sphingomyelin Synthase 1 Regulates Neuro-2a Cell Proliferation and Cell Cycle Progression Through Modulation of p27 Expression and Akt Signaling. Mol Neurobiol (2014) 0.75
p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms. Oncotarget (2016) 0.75
FOXO Signaling Pathways as Therapeutic Targets in Cancer. Int J Biol Sci (2017) 0.75
Sex-related differences of urethane and sodium valproate effects on Ki-67 expression in urethane-induced lung tumors of mice. Exp Ther Med (2017) 0.75
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature (2007) 16.95
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell (1996) 8.77
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature (2000) 8.35
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell (1996) 7.69
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer (2008) 6.22
Modeling the therapeutic efficacy of p53 restoration in tumors. Cell (2006) 5.95
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med (2002) 5.79
Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev (1997) 5.49
The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (1998) 5.40
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med (1997) 5.10
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med (2002) 4.69
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature (1999) 4.35
Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol (2000) 3.93
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell (2007) 3.40
p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev (2004) 3.16
Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol (2004) 3.14
Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell (2007) 3.12
p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell (2005) 2.65
Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol (2003) 2.27
Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res (1995) 2.11
Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev (1997) 2.05
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev (2006) 2.05
Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat Rev Cancer (2004) 1.99
A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J (2002) 1.99
Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci U S A (1989) 1.95
p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res (1995) 1.95
p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res (2001) 1.93
Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res (2005) 1.86
Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol (2003) 1.85
CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. Mol Biol Cell (2003) 1.72
Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc Natl Acad Sci U S A (1999) 1.66
Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization. J Biol Chem (2003) 1.59
Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung Cancer (2001) 1.42
C-terminal phosphorylation controls the stability and function of p27kip1. EMBO J (2006) 1.35
The absence of p27Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa->luteal transition. Cell Growth Differ (1998) 1.34
Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity. J Biol Chem (2000) 1.26
Breast cancer banishes p27 from nucleus. Nat Med (2002) 1.25
Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Oncogene (1999) 1.23
Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell (2002) 1.19
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. Am J Pathol (2005) 1.18
p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer Ther (2008) 1.16
Role of serine 10 phosphorylation in p27 stabilization revealed by analysis of p27 knock-in mice harboring a serine 10 mutation. J Biol Chem (2004) 1.14
Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry. J Biol Chem (2004) 1.14
High expression of Cks1 in human non-small cell lung carcinomas. Biochem Biophys Res Commun (2003) 1.11
Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer. Cell Cycle (2004) 1.10
Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res (1999) 1.02
P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase. Exp Cell Res (2004) 1.01
Multiple mechanisms for p27(Kip1) translocation and degradation. Cell Cycle (2007) 1.01
Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development. Oncogene (2004) 0.99
Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate. Proc Natl Acad Sci U S A (2004) 0.98
Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression. Cancer Res (2007) 0.92
The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (1998) 5.40
The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res (1994) 3.28
p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res (2001) 1.93
A platform for accurate mass and time analyses of mass spectrometry data. J Proteome Res (2007) 1.52
Analysis of intestinal adaptation gene expression by cDNA expression arrays. JPEN J Parenter Enteral Nutr (2001) 1.43
Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res (1995) 1.42
Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat Genet (1995) 1.41
Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis. Curr Biol (2001) 1.38
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med (1990) 1.35
Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene (1991) 1.32
Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Oncogene (1999) 1.23
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med (1985) 1.21
Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation (1993) 1.11
Normal meiotic recombination in p53-deficient mice. Nat Genet (1997) 1.04
p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent. Cancer Res (2001) 1.01
Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J male mice. Carcinogenesis (1988) 1.01
p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene (2007) 0.97
Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells. J Immunol (1989) 0.95
Bax is required for increased enterocyte apoptosis after massive small bowel resection. Surgery (2000) 0.93
Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion. Cancer Res (1994) 0.92
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. II. Sequential changes in alloreactivity of T cell subsets. Transplantation (1989) 0.92
Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha 6 beta 4 intergrin is altered in pre-malignant skin tumors of p53-deficient mice. Int J Cancer (1996) 0.92
Resistance to skin tumorigenesis in DNAPK-deficient SCID mice is not due to immunodeficiency but results from hypersensitivity to TPA-induced apoptosis. Carcinogenesis (1999) 0.91
cDNA microarray analysis of adapting bowel after intestinal resection. J Pediatr Surg (2001) 0.90
Induction of tolerance to heart allografts in rats using posttransplant total lymphoid irradiation and anti-T cell antibodies. Transplantation (1993) 0.89
Effect of massive small bowel resection on the Bax/Bcl-w ratio and enterocyte apoptosis. J Gastrointest Surg (2000) 0.89
Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors. Mol Carcinog (1994) 0.88
p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice. Carcinogenesis (1996) 0.88
Salivary epidermal growth factor and intestinal adaptation in male and female mice. Am J Physiol Gastrointest Liver Physiol (2000) 0.86
p21 (WAF1/CIP1) is required for the mitogenic response to intestinal resection. J Surg Res (2000) 0.84
Immune mechanisms in organ allograft rejection. I. Delayed-type hypersensitivity and lymphocytotoxicity in heart graft rejection. Transplantation (1983) 0.83
Epidermal growth factor alters the bax:bcl-w ratio following massive small bowel resection. J Surg Res (2000) 0.83
Intestinal adaptation and enterocyte apoptosis following small bowel resection is p53 independent. Am J Physiol (1999) 0.83
Immune mechanisms in organ allograft rejection. II. T helper cells, delayed-type hypersensitivity, and rejection of renal allografts. Transplantation (1983) 0.83
DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice. Cancer Res (1998) 0.82
Intestinal adaptation occurs independent of transforming growth factor-alpha. J Pediatr Surg (2000) 0.82
Apoptosis and the pattern of DNase I expression following massive small bowel resection. J Surg Res (1999) 0.82
"The factor of immunization" in allograft rejection: carried by cytotoxic T cells, not helper-inducer T cells. Transplant Proc (1986) 0.78
The possible role of cytotoxic T cells in the mediation of first-set allograft rejection. Transplantation (1985) 0.78
Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D). Transplantation (1983) 0.78
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. V. Dependence of CD4+ suppressor cells on the presence of alloantigen and cytokines, including interleukin 2. Transplantation (1993) 0.77
Genetic determinants of hepatocarcinogenesis in the B6C3F1 mouse. Toxicol Lett (1989) 0.77
Epithelial permeability is not increased in rats following small bowel resection. J Surg Res (2001) 0.76
You don't need a backbone to carry a tumour suppressor gene. Nat Genet (1999) 0.75
Bone marrow transplantation following total lymphoid irradiation. I. Correlation with field size and suppressor cell induction. Transplantation (1983) 0.75
Tempo of induction of W3/25+ suppressor cells in cyclosporine-treated rat cardiac allograft recipients. Transplant Proc (1987) 0.75
Family treatment within the milieu of a residential treatment center. Child Welfare (1971) 0.75
Positive and negative growth control in multistage skin carcinogenesis. Recent Results Cancer Res (1993) 0.75
Functional loss of tumour suppressor genes in multistage chemical carcinogenesis. Princess Takamatsu Symp (1991) 0.75
Genetic and epigenetic promotion of murine hepatocarcinogenesis. Prog Clin Biol Res (1990) 0.75
Immune reactivity and immunosuppressive intervention in experimental nephritis. II. Effect of TLI on the course of two models of nephritis in the inbred rat. J Immunol (1984) 0.75
Correlation of hepatic blood flow as measured by laser Doppler velocimetry with hepatobiliary transport in trout. Proc West Pharmacol Soc (1984) 0.75
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. VI. In vitro alloreactivity of T cell subsets from rats with long-surviving allografts. Transplantation (1993) 0.75
Biliary excretion of [14C]taurocholate by rainbow trout (Salmo gairdneri) is stimulated at warmer acclimation temperature. Comp Biochem Physiol C (1986) 0.75
Immune mechanisms in organ allograft rejection. Transplant Proc (1982) 0.75
Induction of unresponsiveness to organ allografts. A comparison of different immunosuppressive protocols in DA and WF strains of rats. Transplantation (1991) 0.75